Menu Search
Equities

Nuheara Ltd

NUHRF:PKL

Nuheara Ltd

Actions
  • Price (USD)0.0042
  • Today's Change0.00 / 0.00%
  • Shares traded46.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jun 25 2024 18:38 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nuheara Limited is an Australia-based medical device company, which provides smart hearing technology. The principal activity of the Company is the development and commercialization of its hearing technology and products as regulated medical devices. The Company is focused on developing multi-functional, personalized, intelligent hearing devices that augment a person’s hearing. Its products include IQbuds2 MAX, IQstream TV, Bluetooth Transmitter and others. It also offers IQbuds2 replacement parts, which include IQbuds2 MAX (Left or Right), IQbuds2 MAX Charging Case and IQbuds2 MAX Soundport Mesh. The Company has Ear ID technology, which provides research-grade tailored hearing. Its products are sold direct to consumer (DTC) and in consumer electronics retailers, professional hearing clinics, pharmacies and specialty retailers around the world. Its subsidiaries include Nuheara IP Pty Ltd, Nuheara, Inc, Terrace Gold Pty Ltd, Nuheara (UK) Ltd, Nuheara (Canada) Inc and Nuheara NL B.V.

  • Revenue in AUD (TTM)1.93m
  • Net income in AUD-12.62m
  • Incorporated2007
  • Employees--
  • Location
    Nuheara Ltd190 Aberdeen Street, NorthbridgePERTH 6003AustraliaAUS
  • Phone+61 86555-9999
  • Fax+61 86555-9998
  • Websitehttps://www.nuheara.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.